BIT’s 17th Annual International Congress of
Drug Discovery Science & Technology 2019
Theme: The Disruptive, Integrate, Innovation and Development
Time: November 15-17, 2019
Place: Nanjing, China |
Important Activities |
Scientific Program |
|||||||||
Scientific Program |
||
Stream 1301 Pharmaceutical Manufacturing and Integrative Services |
||
Chair: Dr. Tina Tao, Head of APAC E2E Biodevelopment Center, Merck Group, China |
||
Time |
Face On |
Speeches and Speakers |
09:45-09:50 |
Chair's Introduction |
|
09:50-10:10 |
|
Title: Novel Business Model; JRF-RiskShare(R), Discovery to IND |
10:10-10:30 |
|
Title: Feedback on Single-Use Manufacturing and a New Approach for Scale Transfer |
10:30-10:50 |
|
Title: Collaboration and Partnering strategy of Merck |
10:50-11:10 |
|
Title: The changing dynamics of outsourcing- Strategic partnership for effective drug development and manufacturing |
11:10-11:30 | ![]() |
Title: Development of Palatable Glucose Drink for Oral Glucose Tolerance Test to Reduce Biological Variations in Diabetes Population Associate |
11:30-11:50 | ![]() |
Title: What Went Wrong? Pharma Tech Case Studies |
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2003-2019 BIT Group Global Ltd.